Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Urologists prescribe newer medications more often than primary care physicians, who could benefit from more education on treatment options.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Taking 5-ARI before prostate laser surgery may lead to more blood changes, longer surgery, and more urinary issues.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Combining α-blockers with 5α-reductase inhibitors improves symptoms and outcomes for severe benign prostatic hyperplasia.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

The market for these drugs is expected to grow.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.